Article
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
Blood cancer journal - 25 Feb 2020
Guglielmelli Paola, Carobbio Alessandra, Rumi Elisa, De Stefano Valerio, Mannelli Lara, Mannelli Francesco, Rotunno Giada, Coltro Giacomo, Betti Silvia, Cavalloni Chiara, Finazzi Maria Chiara, Thiele Juergen, Cazzola Mario, Vannucchi Alessandro Maria, Barbui Tiziano
Abstract excerpt
Pre-fibrotic myelofibrosis (pre-PMF) and essential thrombocythemia (ET) are characterized by similarly increased rate of thrombotic events, but no study specifically analyzed risk factors for thrombosis in pre-PMF. In a multicenter cohort of 382 pre-PMF patients collected in this study, the rate of arterial and venous thrombosis after diagnosis was 1.0 and 0.95% patients/year. Factors significantly associated...
Topics
Join the communities discussing this publication.
